Vistra Option Alert: Apr 17 $190 Calls at the Bid: 751 vs 8122 OI; Earnings 2/27 Before Open 

Vistra Option Alert: Apr 17 $190 Calls at the Bid: 751 @ $10.7 vs 8122 OI; Earnings 2/27 Before Open Ref=$171.01

Vistra (NYSE:VST) 株価情報

Vistra

Vistra Energy is one of the largest power producers and retail energy providers in the US. Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, solar, and energy storage assets. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.

Movers

Trading Ideas

BIMI

DALN

FFIE

FGEN

GRPN

JTAI

LMND

MGNX

NUZE

PITA

PMEC

POWL

TBIO

TIVC

アドバンスト マイクロ デバイセズ社 (NASDAQ:AMD) の株は、予想を上回る第2四半期決算を受けて本日のプレマーケット取引で急騰している。

AMD株価上昇　決算を受けて

Equities

News

Markets

Media

BBWI

BLDR

EPAM

FSLR

INTC

LULU

NVDA

SMCI

今年の株式市場は、インフレーション圧力の緩和、企業の強い利益、およびAI（人工知能）技術の潜在的な利益に対する楽観的な期待を受けて、連邦準備制度が9月に金利を引き下げるとの期待が高まっています。

S&amp;P500上半期終了も史上最高値を更新せず

DELL

FWONA

NICE

過去1週間でこれらの10つの大型株は最も悪いパフォーマンスを発揮しました。それで、あなたのポートフォリオに含まれていますか？

大型株パフォーマンス下落　NIOを筆頭に

Vistra Corp

Vasta Platform Limited - Class A Ordinary Shares

Vasta Platform Ltd

VISION TECHNOLOGY CORP by Vision Technology Corp.

Vision Technology Corp

Vast Renewables Limited - Ordinary Shares

Vast Renewables Ltd

VNV Global AB

Verastem Inc

VISTA OUTDOOR INC COM

Vestis Corp

Barrington Research analyst Vincent Colicchio maintains Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and maintains $36 price target.

Price Target

Analyst Ratings

HCKT

Barrington Research Maintains Outperform on Hackett Group, Maintains $36 Price Target

CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.93 by 10.75 percent. This is a 30.38 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $275.04 million which beat the analyst consensus estimate of $262.43 million by 4.81 percent. This is a 23.17 percent increase over sales of $223.29 million the same period last year.

Earnings

Earnings Beats

CVLT

CommVault Systems Q4 Adj. EPS $1.03 Beats $0.93 Estimate, Sales $275.04M Beat $262.43M Estimate

Contracts

LASE

Laser Photonics Subsidiary CMS Laser Receives Order From An Appliance Co., Terms Not Disclosed

– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer –
– TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall health –
TORONTO, April 29, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4qcdgVmyeyBVvdSiebSxSXdNR0TXHVOO24ZA5y4iimTZtyj5SNj50d0o4lqmmZrYJ_GzKhtbdKHjhLT_uF3KvKJv7YzY48A8BOmDl8xPwqQ=">Profound Medical Corp.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROF#NASDAQ">PROF</a>, TSX:<a class="ticker" href="https://www.benzinga.com/stock/PRN#TSX">PRN</a>) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, is pleased to announce initial perioperative data from the Level 1 post-market CAPTAIN trial comparing the safety and efficacy of the TULSA procedure with radical prostatectomy ("RP") in men with organ-confined, intermediate-risk, Gleason Score 7 (Grade Group 2 and 3) prostate cancer.
The positive perioperative results were presented yesterday by Xiaosong Meng, M.D., Ph.D., an Assistant Professor in the Department of Urology at UT Southwestern Medical Center, at the American Urological Association ("AUA") Annual Meeting.

PROF

TSX:PRN

Profound Medical Announces Initial Perioperative Data From Level 1 Post-Market CAPTAIN Trial Comparing Safety, Efficacy Of TULSA Procedure With RP In Men With Gleason Score 7 Prostate Cancer

Australia's Alkane Resources (OTCPK: ALKEF)&nbsp; and Canada's Mandalay Resources (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/MNDJF#OTCQB">MNDJF</a>)&nbsp; have announced a "merger of equals "in an all-share transaction valued at approximately AU$1.01 billion ($707 million), creating a diversified <a target="_blank" href="https://www.benzinga.com/topic/gold" rel="noreferrer noopener">gold</a> and antimony producer with global reach.
The newly combined company will retain the Alkane name and remain listed in Australia, but it will seek a dual listing on the Toronto Stock Exchange.
"The transaction will take Alkane to a new level, bringing together two companies with complementary assets and a shared vision for growth," <a target="_blank" href="https://investors.alkane.com.au/site/pdf/88d00faf-747c-4445-87cc-30f033c213b4/Alkane-amp-Mandalay-Merge-to-Create-Gold-amp-Antimony-Producer.pdf" rel="noreferrer noopener">said</a> Nick Earner, Alkane Managing Director. "Mandalay's two high-quality mines match the attributes of Tomingley: a proven history of consistent production, cash generation and exploration upside."
The merger brings together three producing assets across premier mining jurisdictions. Alkane contributes to the Tomingley gold mine in New South Wales, which is currently ramping up production after an expansion.
Mandalay adds its Costerfield gold-antimony mine in Victoria—Australia's only antimony producer—and the Björkdal underground gold mine in Sweden.
The combined group is projected to produce approximately 160,000 gold-equivalent ounces in 2025, increasing to over 180,000 ounces in 2026. Additionally, all-in sustaining costs (AISC) are forecast to drop from AU$2,750/oz in 2025 to AU$2,160/oz in 2026, reflecting improved scale and efficiency.
Frazer Bourchier, Mandalay's President and CEO, noted the merger "presents a compelling opportunity for Mandalay shareholders to accelerate value creation through increased capital markets scale, liquidity and a growing diversified asset base."
"The transaction aligns with our vision to create a mid-tier gold and antimony producer with mines in premier operating jurisdictions and with our strategy for continued growth," he said.
Alkane's Earner will lead the new entity, headquartered in Australia, while industry veteran Andrew Quinn will lead the board, which comprises three directors nominated by Mandalay and two by Alkane.
The pro forma balance sheet includes a robust cash position of AU$188 million ($120 million) as of March 31, 2025, allowing it to pursue further organic growth and strategic opportunities, including advancing Alkane's Boda-Kaiser copper-gold project.
Mandalay shareholders will receive 7.875 Alkane shares for each share they hold, resulting in a 55% stake in the new company, while Alkane shareholders will retain 45%. The transaction has the unanimous support of both boards and major shareholders and is subject to regulatory, shareholder, and court approvals.
The companies expect the deal to close in the second half of 2025, pending regulatory approvals.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45037180/kobold-metals-prepares-billions-to-develop-ethical-sources-of-critical-metals-in-dr-congo" target="_blank" rel="noreferrer noopener">KoBold Metals Prepares Billions To Develop Ethical Sources Of Critical Metals In DR Congo</a></li>
</ul>
Photo by FOTOGRIN via Shutterstock

Commodities

Small Cap

Legal

ALKEF

MNDJF

Alkane And Mandalay Combine In A $707 Million 'Merger Of Equals'

President Donald Trump denied that bond market volatility influenced his decision to implement a 90-day tariff pause on U.S. trading partners, <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">despite significant yield fluctuations</a> that saw the 10-year Treasury yield swing from 3.59% to 4.81% over the past year.
What Happened: &#8220;The bond market was getting the yips, but I wasn&#8217;t,&#8221; Trump <a href="https://time.com/7280114/donald-trump-2025-interview-transcript/">told</a> Time magazine, dismissing speculation that financial market stress prompted the policy reversal. &#8220;I know what we have.&#8221;
The bond market experienced one of its largest short-term moves in recent history during early April, with the 10-year Treasury yield dropping below 4% around April 4 before surging past 4.5% by April 11. Yields move inversely to prices, and higher yields translate to increased borrowing costs affecting mortgages, personal loans, and auto financing.
Market experts had attributed Trump&#8217;s tariff pause to the bond market turbulence. Ed Yardeni of Yardeni Research described the situation as &#8220;bond vigilantes hit another homerun,&#8221; referencing investors who protest inflationary policies by selling <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">bonds to drive yields higher</a>.
Economist Craig Shapiro <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">suggested China&#8217;s threats to sell U.S. Treasuries</a> &#8220;basically blew up the bond market and forced the administration to backtrack,&#8221; while Gary Black of The Future Fund LLC pointed to &#8220;chaos in the bond market&#8221; as a key factor in the &#8220;stunning about face on tariffs.&#8221;
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45061797/us-stock-futures-edge-higher-tuesday-expert-warns-of-perfect-volatility-storm-with-major-earnings-and-economic-data-due-this-week">US Stock Futures Edge Higher Tuesday: Expert Warns Of &#8216;Perfect Volatility Storm&#8217; With Major Earnings And Economic Data Due This Week</a>
Why It Matters: The market reaction to Trump&#8217;s initial tariff announcement was severe, pushing the Nasdaq into bear market territory while the S&amp;P 500 and Dow Jones <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">approached similar declines</a>. When Trump announced the pause via Truth Social, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) surged 10.50% and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) jumped 12.00%.
Trump&#8217;s comments about Federal Reserve Chairman Jerome Powell, whom he called &#8220;Mr. Too Late&#8221; for not cutting interest rates, likely <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">contributed to market volatility</a>, though Trump has since indicated he doesn&#8217;t plan to remove Powell from his position.
Treasury Secretary Scott Bessent claimed <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">the tariff pause was part of Trump&#8217;s strategy</a> from the beginning, stating, &#8220;He and I had a long talk. This was his strategy all along.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/04/45058829/jim-cramer-dismisses-recession-panic-says-tariffs-may-sting-but-too-many-jobs-for-economy-to-derail">Jim Cramer Dismisses Recession Panic: Says Tariffs May Sting, But Too &#8216;Many Jobs&#8217; For Economy To &#8216;Derail&#8217;</a></li>
</ul>
Photo Courtesy: Rawpixel.com on Shutterstock.com
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Bonds

Economics

Trump Says 'Bond Market Was Getting The Yips, But I Wasn't' Amid Tariff Pause As 10-Year Yield Jumps From 3.59% To 4.81%

Stephens &amp; Co. analyst Daniel Imbro maintains PAMT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAMT#NASDAQ">PAMT</a>) with a Equal-Weight and raises the price target from $11 to $12.5.

PAMT

Stephens & Co. Maintains Equal-Weight on PAMT, Raises Price Target to $12.5

Guidance

FOUR

Shift4 Payments Sees Q2 Gross Revenue Less Network	Fees Of $405M - $415M

WIIM

ZBRA

Zebra Technologies shares are trading higher after the company reported better-than-expected Q1 financial results.

Shift4 Payments Sees FY25 Gross Revenue Less Network Fees Of $166B - $1.73B

NeoGenomics Raises FY2025 Adj EPS Guidance from $0.15-$0.19 to $0.16-$0.20 vs $0.18 Est

Stephens &amp; Co. analyst Daniel Imbro downgrades Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) from Overweight to Equal-Weight and lowers the price target from $515 to $255.

Downgrades

SAIA

Stephens & Co. Downgrades Saia to Equal-Weight, Lowers Price Target to $255

BBVA

Banco Bilbao Vizcaya Argentaria shares are trading lower. The company reported Q1 financial results.

Shift4 Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.71 by 50.7 percent. This is a 98.15 percent increase over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $848.30 million which missed the analyst consensus estimate of $868.30 million by 2.30 percent. This is a 19.92 percent increase over sales of $707.40 million the same period last year.

Earnings Misses

Shift4 Payments Q1 Adj. EPS $1.07 Beats $0.71 Estimate, Sales $848.30M Miss $868.30M Estimate

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/04/28/final-trades-goldman-sachs-apollo-global-qualcomm-and-check-point.html">Halftime Report Final Trades</a>,&#8221; Stephen L. Weiss of Short Hills Capital Partners named The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) as <a href="https://www.benzinga.com/quote/GS/earnings">his final trade</a>.
On the earnings front, Goldman Sachs reported quarterly earnings of $14.12 per share on April 14, beating the analyst consensus estimate of $12.35 per share. The firm also reported quarterly sales of $15.06 billion, beating the analyst consensus estimate of $14.81 billion.
Bryn Talkington, Managing Partner of Requisite Capital Management, said Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) will release earnings this Friday.
Analysts expect the company to report quarterly earnings at $1.85 per share on revenue of $964.53 million.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners picked QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) as his final trade, which is scheduled to release earnings results for its second quarter on Wednesday, April 30, after the closing bell.
Analysts expect the company to report quarterly earnings at $2.81 per share on revenue of $10.65 billion.
Joseph M. Terranova of Virtus Investment Partners picked Check Point Software Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) after last week's selloff following earnings report.
On April 23, the company reported quarterly revenue growth of 7% year over year to $637.8 million, topping the analyst consensus estimate of $636.2 million.
Price Action:
<ul>
<li>Goldman Sachs shares gained 0.3% to close at $546.40 on Monday.</li>
<li>Apollo Global gained 2.2% to close at $136.36 during Monday's session.</li>
<li>Qualcomm shares fell 0.6% to close at $147.62 on Monday.</li>
<li>Check Point Software shares climbed 2.8% to settle at $212.41 during the session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Image: Shutterstock

Long Ideas

CHKP

QCOM

Goldman Sachs, Qualcomm, Apollo Global And A Tech Stock On CNBC's 'Final Trades'

Novel Gene Therapy Program Offers a Promising Opportunity for Curative Therapy in Diabetes
AUSTIN, Texas, April 29, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4415379-1&amp;h=3725234881&amp;u=https%3A%2F%2Fwww.genprex.com%2F&amp;a=Genprex%2C+Inc.">Genprex, Inc.</a> ("Genprex" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators have been selected to present at the upcoming American Society of Gene and Cell Therapy's (ASGCT) 28th Annual Meeting being held May 13-17, 2025 in New Orleans, Louisiana. The collaborators will present positive preclinical data and research from studies of GPX-002, the Company's diabetes gene therapy drug candidate.

GNPX

Genprex Collaborators To Present Preclinical Data And Research From Studies Of GPX-002, Diabetes Gene Therapy, At ASGCT 28Th Annual Meeting

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading higher after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.

As President Donald Trump marks 100 days in office, four tech giants who backed his second term have seen their fortunes and their companies&#8217; stock values take a hit. 
What Happened: Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Founder Jeff Bezos, Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg, and Nvidia CEO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Jensen Huang who have donated or attended Trump&#8217;s inauguration have collectively lost nearly $195 billion since Jan. 20, as per Bloomberg Billionaire Index.
Musk, serves as an advisor to the Trump administration, has experienced the most significant wealth decline of $114 billion, despite remaining the world&#8217;s richest person. After protests targeting Tesla Inc. Musk announced last week that he will scale back his involvement with the White House DOGE office in May. Tesla shares have fallen nearly 25% this year after underwhelming quarterly earnings.
Bezos's fortune—mostly linked to his Amazon Inc shares—has dropped $36 billion since January 20. Analysts say Amazon is especially exposed to Trump's trade war and the 145% tariff on China due to the high volume of Chinese goods sold on its platform.
Zuckerberg's fortune, tied to Meta Platforms, is under pressure as the company faces a government antitrust lawsuit. At the same time, Huang's wealth—largely based on Nvidia Corporation stock—has taken a hit since his appearance at the inauguration. Nvidia shares are down over 21% year to date, and the company expects a $5.5 billion blow to first-quarter earnings due to Trump's restrictions on chip exports to China.
The news was <a href="https://www.businessinsider.com/tech-billionaires-wealth-dropped-trump-100-days-inauguration-2025-4">first</a> reported by Business Insider.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a>
Why It Matters: Trump&#8217;s reciprocal tariffs have threatened to undermine <a href="https://www.benzinga.com/25/04/44641631/trumps-reciprocal-tariffs-threaten-to-derail-big-techs-billion-dollar-ai-infrastructure-plans-analysts-warn-stargate-was-already-unlikely-to-get-to-that-scale">billion-dollar</a> AI infrastructure projects being spearheaded by leading tech companies. These tariffs have been described as &#8216;Armageddon&#8217; for the sector, with tech leaders who backed Trump losing a <a href="https://www.benzinga.com/personal-finance/25/04/44884750/tech-leaders-who-backed-trump-have-lost-1-8-trillion-tariffs-described-as-armageddon-for-the-sector">combined </a>$1.8 trillion due to tariffs by April 18. 
Furthermore, the European Commission president Ursula von der Leyen <a href="https://www.benzinga.com/markets/25/04/44784857/eu-threatens-additional-taxes-on-us-tech-giants-amid-ongoing-tariff-war-we-are-developing-retaliatory-measures-says-von-der-leyen">warned </a>that big U.S. tech firms could end up paying up if Trump tariff talks collapse, EU threatened additional taxes on American tech giants amid ongoing trade war.
Meanwhile, according to a CNN poll, Donald Trump&#8217;s 41% approval rating is the lowest of any newly elected president at the 100-day mark since Dwight Eisenhower — even lower than during Trump's first term.
Vanguard Information Technology Index Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGT#NYSE">VGT</a>) declined 12.2% year-to-date while SPDR NYSE Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XNTK#NYSE">XNTK</a>) lost 3.56%.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/tech/25/04/45060194/godfather-of-ai-geoffrey-hinton-backs-elon-musk-in-fight-against-openais-restructuring-id-like-to-stop-them-" target="_blank" rel="noreferrer noopener">&#8216;Godfather Of AI&#8217; Geoffrey Hinton Backs Elon Musk In Fight Against OpenAI&#8217;s Restructuring: &#8216;I&#8217;d Like To Stop Them From Completely Gutting It&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

AMZN

TSLA

XNTK

As Trump Completes 100 Days As President, Elon Musk, Jeff Bezos, Mark Zuckerberg And Other Billionaire Backers See $195 Billion Wealth Wipeout Amid Market Turmoil

Wolfe Research analyst Mike Polark downgrades Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) from Outperform to Peer Perform.

PODD

Wolfe Research Downgrades Insulet to Peer Perform

Sherwin-Williams shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results above estimates.

With 288% Growth This Year, Is the S&P 500's Rising Star Still Worth the Investment?

Offerings

Press Releases

Vistra Announces Private Offering of Senior Secured Notes

Vistra Prices Private Offering of $1.25 Billion of Senior Secured Notes

Dynegy and Homefield Energy Announce Recipients of the 2024 Energy Leadership Awards

Vistra Connects Two Utility-Scale Solar Facilities to Grid and Extends Operations of Baldwin Power Plant in Response to Reliability Concerns in MISO

Vistra Announces Expansion of its Board of Directors with the Appointment of Rob Walters

Vistra to Report Full Year and Fourth Quarter 2024 Results on Feb. 27, 2025

Dividends

Vistra Declares Dividend on Common Stock and Series A Preferred Stock

Vistra Reports Fourth Quarter and Full-Year 2024 Results

Vistra to Report First Quarter Results on May 7, 2025

AleAnna

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Comments

Vistra

Unusual Options Activity for

ニュース

パートナーシップ

ベンジンガ・グローバル